Quarterly report [Sections 13 or 15(d)]

Selected Financial Statement - Liabilities - Schedule of Accounts Payable and Accrued Expenses (Details)

v3.25.2
Selected Financial Statement - Liabilities - Schedule of Accounts Payable and Accrued Expenses (Details) - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Accounts payable:    
Clinical and regulatory expenses $ 540 $ 452
Professional fees 661 904
Selling expenses 1,420 1,553
Manufacturing costs 209 706
Non-employee director compensation 982 966
Other vendors 750 594
Total accounts payable 4,562 5,175
Accrued interest payable, related parties 1,372 1,145
Accrued interest payable 4,407 2,874
Accrued expenses:    
Payroll expenses 545 323
Government rebates and other rebates 8,130 7,229
Other accrued expenses 357 180
Total accrued expenses 9,032 7,732
Total accounts payable and accrued expenses $ 19,373 $ 16,926